Austedo

Active Ingredient(s): Deutetrabenazine
FDA Approved: * April 3, 2017
Pharm Company: * TEVA PHARMS USA INC
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Austedo Overview

Deutetrabenazine (trade name Austedo) is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington’s disease and tardive dyskinesia. Chemically, deutetrabenazine is an isotopic isomer of tetrabenazine in which six hydrogen atoms have been replaced by deuterium atoms. The incorporation of deuterium slows the rate of drug metabolism, allowing less frequent dosing.[1][2] Efficacy A Lancet study pub...

Read more Austedo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deutetrabenazine

Recent Austedo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Deutetrabenazine
  • Tablet: 12mg, 6mg, 9mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Austedo: (3 results)

Sorted by National Drug Code
  • 68546-170 Austedo 6 mg Oral Tablet, Coated by Teva Neuroscience, Inc.
  • 68546-171 Austedo 9 mg Oral Tablet, Coated by Teva Neuroscience, Inc.
  • 68546-172 Austedo 12 mg Oral Tablet, Coated by Teva Neuroscience, Inc.

Other drugs which contain Deutetrabenazine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA